DEEPAK NITRITEIn early January, the stock faced rejection around 2520 levels and it retreated to sub 200 DMA levels. From there, it recovered. In early May, it made an attempt to take out the price rejection zone. There was a move on very high volume. Unfortunately, that move did not succeed and it was pushed bac
